|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.8704 USD | +2.40% |
|
+10.61% | +22.33% |
| Jun. 29 | Tenaya Therapeutics, Inc. Announces Management Changes, Effective July 13, 2026 | CI |
| Jun. 29 | Tenaya Therapeutics, Inc. Announces Chief Financial Officer Changes, Effective July 13, 2026 | CI |
Business description: Tenaya Therapeutics, Inc.
Number of employees: 70
Sales by Activity: Tenaya Therapeutics, Inc.
| Fiscal Period: December | 2021 (USD) | 2022 (USD) | 2023 (USD) | 2024 (USD) | 2025 (USD) |
|---|
Geographical breakdown of sales: Tenaya Therapeutics, Inc.
| Fiscal Period: December | 2021 (USD) | 2022 (USD) | 2023 (USD) | 2024 (USD) | 2025 (USD) |
|---|
Executive Committee: Tenaya Therapeutics, Inc.
| Manager | Title | Age | Since |
|---|---|---|---|
Faraz Ali
CEO | Chief Executive Officer | 53 | 2018-05-31 |
Kathy Ivey
CTO | Chief Tech/Sci/R&D Officer | - | 2024-06-26 |
| Chief Tech/Sci/R&D Officer | - | - | |
Kee-Hong Kim
CTO | Chief Tech/Sci/R&D Officer | - | 2018-09-30 |
| Chief Tech/Sci/R&D Officer | 58 | 2018-11-30 |
Composition of the Board of Directors: Tenaya Therapeutics, Inc.
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 59 | 2016-09-30 | |
Faraz Ali
BRD | Director/Board Member | 53 | 2018-08-31 |
Robert Williams
CHM | Chairman | 77 | 2024-12-31 |
| Director/Board Member | 63 | 2020-05-31 | |
Jeffrey Walsh
BRD | Director/Board Member | 60 | 2020-02-29 |
June Lee
BRD | Director/Board Member | 60 | 2021-11-18 |
Karah Parschauer
BRD | Director/Board Member | 48 | 2021-12-21 |
Amy Burroughs
BRD | Director/Board Member | 55 | 2022-12-06 |
Company details: Tenaya Therapeutics, Inc.
Tenaya Therapeutics, Inc.
171 Oyster Point Boulevard
94080, South San Francisco
+
http://www.tenayatherapeutics.com
Other Biotechnology & Medical Research
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.40% | +10.61% | +27.40% | -84.48% | 189M | |
| -0.39% | +0.48% | +3.29% | +9.79% | 50.73B | |
| -2.22% | -1.25% | +391.53% | +593.69% | 39.73B | |
| -0.54% | +0.39% | +27.67% | -5.10% | 34.69B | |
| -1.36% | +0.35% | +19.34% | +55.53% | 33.21B | |
| +1.21% | -4.58% | +3.00% | +31.73% | 26.76B | |
| -1.81% | -1.48% | - | - | 16.8B | |
| +0.51% | -3.47% | +66.38% | +122.57% | 15.37B | |
| -0.15% | +0.23% | +14.46% | +16.24% | 13.78B | |
| -0.62% | -3.09% | +11.43% | -31.02% | 12.85B | |
| Average | +0.20% | +0.31% | +62.72% | +78.77% | 24.41B | |
| Weighted average by Cap. | -0.03% | -0.22% | +82.61% | +124.48% |
Sector
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TNYA Stock
- Company Tenaya Therapeutics, Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
